Research Article

The impact of pre-transplant fibrinogen and D-dimer levels on transplantation outcomes in autologous stem cell transplantation

Volume: 8 Number: 4 July 30, 2025
TR EN

The impact of pre-transplant fibrinogen and D-dimer levels on transplantation outcomes in autologous stem cell transplantation

An Erratum to this article was published on September 16, 2025. https://dergipark.org.tr/en/pub/jhsm/article/1784678

Abstract

Aims: Determine how serum D-dimer and fibrinogen levels affect the prognosis of patients undergoing autologous hematopoietic stem cell transplantation (auto-HSCT) within the context of underlying hematologic malignancies. Methods: This retrospective study included 152 adult patients who received auto-HSCT between 2010 and 2024. D-dimer and fibrinogen levels were documented prior to the transplant. Survival analyses were performed with Kaplan-Meier curves and Cox regression methods. ROC analysis provided cut-off values. Results: The D-dimer and fibrinogen cut-off levels of >860 ng/ml and >448 mg/dl, respectively, were statistically significant with increased rates of relapse and mortality. Mortality was independently predicted by D-dimer and fibrinogen (HR: 96.74 and 5.478) and relapse (HR: 24.254 and 6.921). Increased levels of the markers significantly reduced the five-year overall survival. Conclusion: Auto-HSCT patients with elevated D-dimer and fibrinogen have unfavorable prognoses and poor outcomes. The inexpensive nature of these biomarkers allows greater ease in establishing risk stratification for targeted pre-transplant planning.

Keywords

Supporting Institution

The authors received no financial support for the research, authorship, and/or publication of this article.

Ethical Statement

This study was approved by the Erciyes University Clinical Research Ethics Committee (Approval No: 2025/31, Date: 22.01.2025).

References

  1. Al Hamed R, Bazarbachi AH, Malard F, Harousseau JL, Mohty M. Current status of autologous stem cell transplantation for multiple myeloma. Blood Cancer J. 2019;9(4):44. doi:10.1038/s41408-019-0205-9
  2. Zahid U, Akbar F, Amaraneni A, et al. A review of autologous stem cell transplantation in lymphoma. Curr Hematol Malig Rep. 2017;12(3):217-226. doi:10.1007/s11899-017-0382-1
  3. Vijenthira A, Gong IY, Fox TA, et al. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients. Blood. 2020;136(25):2881-2892. doi:10. 1182/blood.2020008824
  4. Linkins LA, Takach Lapner S. Review of D-dimer testing: good, bad, and ugly. Int J Lab Hematol. 2017;39(Suppl 1):98-103. doi:10.1111/ijlh.12665
  5. Weitz JI, Fredenburgh JC, Eikelboom JW. A test in context: D-dimer. J Am Coll Cardiol. 2017;70(19):2411-2420. doi:10.1016/j.jacc.2017.09.024
  6. Franchini M, Focosi D, Pezzo MP, Mannucci PM. How we manage a high D-dimer. Haematologica. 2023;109(4):1035-1045. doi:10.3324/haematol.2023.283966
  7. Schafer K, Goldschmidt E, Oostra D, Fish J, Russell T, Lurie F. The clinical significance of ultra-high D-dimer levels. J Vasc Surg Venous Lymphat Disord. 2022;10(1):8-13. doi:10.1016/j.jvsv.2021.06.011
  8. Ozen M, Yilmaz A, Cakmak V, et al. D-dimer as a potential biomarker for disease severity in COVID-19. Am J Emerg Med. 2021;40:55-59. doi: 10.1016/j.ajem.2020.12.023

Details

Primary Language

English

Subjects

Haematology

Journal Section

Research Article

Publication Date

July 30, 2025

Submission Date

June 1, 2025

Acceptance Date

June 26, 2025

Published in Issue

Year 2025 Volume: 8 Number: 4

APA
Mandacı Şanlı, N., & Mandacı, E. D. (2025). The impact of pre-transplant fibrinogen and D-dimer levels on transplantation outcomes in autologous stem cell transplantation. Journal of Health Sciences and Medicine, 8(4), 621-628. https://doi.org/10.32322/jhsm.1711682
AMA
1.Mandacı Şanlı N, Mandacı ED. The impact of pre-transplant fibrinogen and D-dimer levels on transplantation outcomes in autologous stem cell transplantation. J Health Sci Med / JHSM. 2025;8(4):621-628. doi:10.32322/jhsm.1711682
Chicago
Mandacı Şanlı, Neslihan, and Edanur Dilara Mandacı. 2025. “The Impact of Pre-Transplant Fibrinogen and D-Dimer Levels on Transplantation Outcomes in Autologous Stem Cell Transplantation”. Journal of Health Sciences and Medicine 8 (4): 621-28. https://doi.org/10.32322/jhsm.1711682.
EndNote
Mandacı Şanlı N, Mandacı ED (July 30, 2025) The impact of pre-transplant fibrinogen and D-dimer levels on transplantation outcomes in autologous stem cell transplantation. Journal of Health Sciences and Medicine 8 4 621–628.
IEEE
[1]N. Mandacı Şanlı and E. D. Mandacı, “The impact of pre-transplant fibrinogen and D-dimer levels on transplantation outcomes in autologous stem cell transplantation”, J Health Sci Med / JHSM, vol. 8, no. 4, pp. 621–628, July 2025, doi: 10.32322/jhsm.1711682.
ISNAD
Mandacı Şanlı, Neslihan - Mandacı, Edanur Dilara. “The Impact of Pre-Transplant Fibrinogen and D-Dimer Levels on Transplantation Outcomes in Autologous Stem Cell Transplantation”. Journal of Health Sciences and Medicine 8/4 (July 30, 2025): 621-628. https://doi.org/10.32322/jhsm.1711682.
JAMA
1.Mandacı Şanlı N, Mandacı ED. The impact of pre-transplant fibrinogen and D-dimer levels on transplantation outcomes in autologous stem cell transplantation. J Health Sci Med / JHSM. 2025;8:621–628.
MLA
Mandacı Şanlı, Neslihan, and Edanur Dilara Mandacı. “The Impact of Pre-Transplant Fibrinogen and D-Dimer Levels on Transplantation Outcomes in Autologous Stem Cell Transplantation”. Journal of Health Sciences and Medicine, vol. 8, no. 4, July 2025, pp. 621-8, doi:10.32322/jhsm.1711682.
Vancouver
1.Neslihan Mandacı Şanlı, Edanur Dilara Mandacı. The impact of pre-transplant fibrinogen and D-dimer levels on transplantation outcomes in autologous stem cell transplantation. J Health Sci Med / JHSM. 2025 Jul. 30;8(4):621-8. doi:10.32322/jhsm.1711682

 

Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS].

The Directories (indexes) and Platforms we are included in are at the bottom of the page.
 

Note: Our journal is not WOS indexed and therefore is not classified as Q.
 

You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/2316/file/4905/show
 



 

 


 


 


 

The indexes of the journal are ULAKBİM TR Dizin, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, etc.

       images?q=tbn:ANd9GcRB9r6zRLDl0Pz7om2DQkiTQXqDtuq64Eb1Qg&usqp=CAU
 
500px-WorldCat_logo.svg.png
 
atifdizini.png
 
logo_world_of_journals_no_margin.png
 
images?q=tbn%3AANd9GcTNpvUjQ4Ffc6uQBqMQrqYMR53c7bRqD9rohCINkko0Y1a_hPSn&usqp=CAU
 
doaj.png  
 
images?q=tbn:ANd9GcSpOQFsFv3RdX0lIQJC3SwkFIA-CceHin_ujli_JrqBy3A32A_Tx_oMoIZn96EcrpLwTQg&usqp=CAU
 
ici2.png
 
download?token=eyJhdXRoX3JvbGVzIjpbXSwiZW5kcG9pbnQiOiJqb3VybmFsIiwib3JpZ2luYWxuYW1lIjoiYXNvcy1pbmRleC5wbmciLCJwYXRoIjoiNzllOC83YmFmLzJiMjgvNmFiY2ZhMzEyNzM5ZjIuMjE4ODU2NDkucG5nIiwiZXhwIjoxNzkwNzczMzEzLCJub25jZSI6IjhiMGRiNjFhODNlYmVmZmE2YjNmN2EwOGYzMzA3ODliIn0.gjgi0RUry9ZVQ3VIGQ_LLtXXaucKgrYlJHaZRbUjeFA
 
drji.png
 


 


 


 


 

The platforms of the journal are Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons, etc.

COPE-logo-300x199.jpgimages?q=tbn:ANd9GcQR6_qdgvxMP9owgnYzJ1M6CS_XzR_d7orTjA&usqp=CAU
 
icmje_1_orig.png
 
cc.logo.large.png
 
images?q=tbn:ANd9GcRBcJw8ia8S9TI4Fun5vj3HPzEcEKIvF_jtnw&usqp=CAU
 
download?token=eyJhdXRoX3JvbGVzIjpbXSwiZW5kcG9pbnQiOiJqb3VybmFsIiwib3JpZ2luYWxuYW1lIjoiTkNCSS5wbmciLCJwYXRoIjoiZTI1YS8zYTM4LzE5NDMvNmFiY2ZhNjJhOWZkNzcuOTg0MjQ3NjkucG5nIiwiZXhwIjoxNzkwNzczMzYzLCJub25jZSI6ImMwY2I0ZWU0NzIxMmYwYzE3ZmI5Y2IxOGVjZjcyYzY1In0.67po-eeRW5x3P2Yk74aT4djgxFWtOm7oxuE79R9KJvw
 
1*mvsP194Golg0Dmo2rjJ-oQ.jpeg
 


 

Our Journal using the DergiPark system indexed are;

Ulakbim TR Dizin,  Index Copernicus, ICI World of Journals, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, OpenAIRE, MIAR,  EuroPub, WorldCat (OCLC), DOAJ,  Türkiye Citation Index, Türk Medline Index, InfoBase Index


 

Our Journal using the DergiPark system platforms are;
 

Google, Google Scholar, CrossRef (DOI), ResearchBib, ICJME, COPE, NCBI, ORCID, Creative Commons, Open Access, and etc.

 

Journal articles are evaluated as "Double-Blind Peer Review". 
 

 

Our journal has adopted the Open Access Policy and articles in JHSM are Open Access and fully comply with Open Access instructions. All articles in the system can be accessed and read without a journal user.  https//dergipark.org.tr/tr/pub/jhsm/page/9535

Journal charge policy   https://dergipark.org.tr/tr/pub/jhsm/page/10912

Our journal has been indexed in DOAJ as of May 18, 2020.

Our journal has been indexed in TR-Dizin as of March 12, 2021.
 

 

17873
 

Articles published in Journal of Health Sciences and Medicine have open access and are licensed under the Creative Commons CC BY-NC-ND 4.0 International License.